Neuroscience for addiction medicine : from prevention to rehabilitation : methods and interventions

458 Pages·2016·18.73 MB·English

by  Ekhtiari

Serial Editor
Vincent Walsh
InstituteofCognitiveNeuroscience
UniversityCollegeLondon
17QueenSquare
LondonWC1N3ARUK
Editorial Board
MarkBear, Cambridge, USA.
Medicine& TranslationalNeuroscience
Hamed Ekhtiari, Tehran, Iran.
Addiction
Hajime Hirase, Wako, Japan.
NeuronalMicrocircuitry
Freda Miller, Toronto,Canada.
DevelopmentalNeurobiology
ShaneO’Mara, Dublin, Ireland.
Systems Neuroscience
SusanRossell, Swinburne, Australia.
Clinical Psychology&Neuropsychiatry
Nathalie Rouach, Paris, France.
Neuroglia
Barbara Sahakian,Cambridge, UK.
Cognition &Neuroethics
Bettina Studer,Dusseldorf,Germany.
Neurorehabilitation
Xiao-Jing Wang, New York, USA.
ComputationalNeuroscience
Elsevier
Radarweg29,POBox211,1000AEAmsterdam,Netherlands
TheBoulevard,LangfordLane,Kidlington,OxfordOX51GB,UK
50HampshireStreet,5thFloor,Cambridge,MA02139,USA
Firstedition2016
Copyright#2016ElsevierB.V.Allrightsreserved
Nopartofthispublicationmaybereproducedortransmittedinanyformorbyanymeans,
electronicormechanical,includingphotocopying,recording,oranyinformationstorageand
retrievalsystem,withoutpermissioninwritingfromthepublisher.Detailsonhowtoseek
permission,furtherinformationaboutthePublisher’spermissionspoliciesandour
arrangementswithorganizationssuchastheCopyrightClearanceCenterandtheCopyright
LicensingAgency,canbefoundatourwebsite:www.elsevier.com/permissions.
Thisbookandtheindividualcontributionscontainedinitareprotectedundercopyrightbythe
Publisher(otherthanasmaybenotedherein).
Notices
Knowledgeandbestpracticeinthisfieldareconstantlychanging.Asnewresearchand
experiencebroadenourunderstanding,changesinresearchmethods,professionalpractices,or
medicaltreatmentmaybecomenecessary.
Practitionersandresearchersmustalwaysrelyontheirownexperienceandknowledgein
evaluatingandusinganyinformation,methods,compounds,orexperimentsdescribedherein.
Inusingsuchinformationormethodstheyshouldbemindfuloftheirownsafetyandthesafety
ofothers,includingpartiesforwhomtheyhaveaprofessionalresponsibility.
Tothefullestextentofthelaw,neitherthePublishernortheauthors,contributors,oreditors,
assumeanyliabilityforanyinjuryand/ordamagetopersonsorpropertyasamatterofproducts
liability,negligenceorotherwise,orfromanyuseoroperationofanymethods,products,
instructions,orideascontainedinthematerialherein.
ISBN:978-0-444-63716-1
ISSN:0079-6123
ForinformationonallElsevierpublications
visitourwebsiteathttp://store.elsevier.com/
Contributors
Woo Young Ahn
Department ofPsychiatry, Institute for Drug and Alcohol Studies, Virginia
CommonwealthUniversity, Richmond,VA, and Department ofPsychology,
The Ohio State University, Columbus, OH, USA
Nelly Alia-Klein
Department ofPsychiatry, IcahnSchoolofMedicineatMountSinai, NewYork,
NY, USA
AlbertBatalla
DepartmentofPsychiatryandPsychology,HospitalCl´ınic,IDIBAPS,CIBERSAM,
University ofBarcelona,Barcelona,Spain, and Department ofPsychiatry,
Radboud University MedicalCentre,Nijmegen,The Netherlands
SamanthaBrooks
DepartmentofPsychiatryandMRCUnitonAnxiety&StressDisorders,University
ofCape Town, Cape Town, South Africa
GregoryG. Brown
DepartmentofPsychiatry,UniversityofCalifornia,SanDiego,LaJolla,CA,USA
JeromeR.Busemeyer
Department ofPsychologicaland Brain Sciences, IndianaUniversity,
Bloomington, IN, USA
ElizabethCabrera
NationalInstituteonAlcoholAbuseandAlcoholism,NationalInstitutesofHealth,
Bethesda, MD, USA
Salvatore Campanella
Laboratoire de Psychologie M(cid:1)edicale etd’Addictologie, ULBNeuroscience
Institute(UNI),CHUBrugmann-Universit(cid:1)eLibredeBruxelles(U.L.B.),Brussels,
Belgium
Nazzareno Cannella
Institute ofPsychopharmacology, CentralInstituteof Mental Health, Medical
FacultyMannheim/Heidelberg University, Mannheim, Germany
Daniele Caprioli
Behavioral Neuroscience Research Branch,Intramural Research Program,
NIDA,NIH, Baltimore, MD, USA
Sandra Carvalho
Department ofPhysical Medicineand Rehabilitation, Laboratory of
Neuromodulation,SpauldingRehabilitationHospitalandMassachusettsGeneral
Hospital, Harvard MedicalSchool,Boston, MA, USA, and
Neuropsychophysiology Laboratory, CIPsi, School of Psychology (EPsi),
University ofMinho, Braga, Portugal
v
vi Contributors
BaderChaarani
Departmentsof Psychiatryand Psychology, University ofVermont,Burlington,
VT, USA
Roberto Ciccocioppo
SchoolofPharmacy,PharmacologyUnit,UniversityofCamerino,Camerino,Italy
Patricia Conrod
Department ofPsychiatry, Universit(cid:1)ede Montreal, CHU Ste Justine Hospital,
Montreal, QC, Canada
Janna Cousijn
DepartmentofPsychiatryandMRCUnitonAnxiety&StressDisorders,University
of Cape Town, Cape Town, SouthAfrica
AlainDagher
Montreal Neurological Institute,McGillUniversity, Montreal, QC, Canada
Junyi Dai
Centre for Adaptive Rationality, Max Planck Institute for Human Development,
Berlin, Germany
Michielde Ruiter
Department ofPsychosocial Research and Epidemiology, Netherlands Cancer
Institute, Amsterdam, The Netherlands
Sylvane Desrivieres
Institute ofPsychiatry, King’sCollege London, London,UK
EliseE.DeVito
DepartmentofPsychiatry,SchoolofMedicine,YaleUniversity,NewHaven,CT,
USA
Hamed Ekhtiari
ResearchCenterforMolecularandCellularImaging;NeurocognitiveLaboratory,
IranianNationalCenter for AddictionStudies(INCAS); Translational
NeuroscienceProgram, Institute for CognitiveSciences Studies(ICSS),and
Neuroimaging and Analysis Group, ResearchCenter for MolecularandCellular
Imaging (RCMCI), Tehran University of Medical Sciences, Tehran, Iran
AshkanFaghiri
ResearchCenter for MolecularandCellular Imaging,TehranUniversity of
MedicalSciences,andDepartmentofElectricalEngineering,SharifUniversityof
Technology, Tehran, Iran
SarahW. FeldsteinEwing
Department ofPsychiatry, Oregon Health& Science University, Portland, OR,
USA
Felipe Fregni
Department ofPhysical Medicine and Rehabilitation, Laboratory of
Neuromodulation,SpauldingRehabilitationHospitalandMassachusettsGeneral
Hospital, Harvard Medical School, Boston, MA, USA
Contributors vii
Hugh Garavan
Departments ofPsychiatry and Psychology, University of Vermont, Burlington,
VT, USA
ThomasE. Gladwin
AddictionDevelopment and Psychopathology (ADAPT)Lab,Department
ofPsychology, University ofAmsterdam, Amsterdam,and Research
Centre—Military MentalHealth,Ministry of Defense,Utrecht,The Netherlands
David C.Glahn
Department ofPsychiatry, YaleUniversity SchoolofMedicine, New Haven, CT,
USA
Rita Z.Goldstein
DepartmentofPsychiatry,andDepartmentofPsychiatry&Neuroscience,Icahn
SchoolofMedicineatMountSinai, NewYork, NY, USA
Anna E.Goudriaan
DepartmentofPsychiatryandMRCUnitonAnxiety&StressDisorders,University
ofCape Town, Cape Town, South Africa, and Department of Psychiatry,
University ofAmsterdam, Amsterdam, The Netherlands
Joshua L. Gowin
Section on Human Psychopharmacology, Intramural Research Program,
NationalInstituteonAlcoholAbuseandAddiction,NationalInstitutesofHealth,
Bethesda, MD, USA
Markus Heilig
Center for Social and Affective Neuroscience, Department ofClinical and
Experimental Medicine, Link€opingUniversity, Link€oping, Sweden
Mary M. Heitzeg
Department ofPsychiatry, University ofMichigan, Ann Arbor, MI, USA
Marcus Herdener
Center for AddictiveDisorders, Department ofPsychiatry, Psychotherapy and
Psychosomatics,Psychiatric Hospital, University ofZurich, Zurich, Switzerland
Derrek P.Hibar
Department ofNeurology, Imaging Genetics Center, Keck School of Medicine,
University ofSouthern California,MarinadelRey,CA, USA
Kent Hutchison
Department ofPsychology and Neuroscience, University ofColorado Boulder,
Boulder,CO, USA
Joanna Jacobus
DepartmentofPsychiatry,UniversityofCalifornia,SanDiego,LaJolla,CA,USA
Neda Jahanshad
Department ofNeurology, Imaging Genetics Center, Keck School of Medicine,
University ofSouthern California,MarinadelRey,CA, USA
viii Contributors
Kees-Jan Kan
Departmentsof Psychiatryand Psychology, University ofVermont,Burlington,
VT, USA
Bernard LeFoll
Translational Addiction Research Laboratory, CampbellFamily Mental Health
ResearchInstitute;AddictionMedicineService,AmbulatoryCareandStructured
Treatments,CentreforAddictionandMentalHealth,andDepartmentofFamily
andCommunityMedicine,PharmacologyandToxicology,Psychiatry,Instituteof
MedicalSciences, University ofToronto,Toronto,ON, Canada
Lorenzo Leggio
Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology,
Laboratory of Clinical and Translational Studies, NationalInstitute on Alcohol
AbuseandAlcoholism,andIntramuralResearchProgram,NationalInstituteon
DrugAbuse,Bethesda, MD, USA
Jorge Leite
Department ofPhysical Medicine and Rehabilitation, Laboratory of
Neuromodulation,SpauldingRehabilitationHospitalandMassachusettsGeneral
Hospital, Harvard Medical School, Boston, MA, USA, and
Neuropsychophysiology Laboratory,CIPsi,School ofPsychology(EPsi),
University ofMinho,Braga, Portugal
Chiang-Shan R.Li
Department ofPsychiatry, YaleUniversity School of Medicine,New Haven,CT,
USA
Edythe D.London
Department ofPsychiatry, Icahn School of Medicine atMount Sinai,New York,
NY,andDavidGeffenSchoolofMedicine,UniversityofCaliforniaatLosAngeles,
LosAngeles, CA, USA
Valentina Lorenzetti
SchoolofPsychologicalSciences, Monash Institute ofCognitive and Clinical
Neurosciencesand Monash Biomedical Imaging,Monash University,
Melbourne, Australia
Maartje Luijten
Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands
ScottMackey
Departmentsof Psychiatryand Psychology, University ofVermont,Burlington,
VT, USA
RocioMartin-Santos
DepartmentofPsychiatryandPsychology,HospitalClı´nic,IDIBAPS,CIBERSAM,
University ofBarcelona,Barcelona,Spain
AprilC. May
Department ofPsychiatry, University ofCalifornia, San Diego, CA, USA
Contributors ix
BenjaminMcKenna
DepartmentofPsychiatry,UniversityofCalifornia,SanDiego,LaJolla,CA,USA
Scott J. Moeller
DepartmentsofPsychiatry&Neuroscience,IcahnSchoolofMedicineatMount
Sinai,NY, USA
Reza Momenan
SectiononBrainElectrophysiologyandImaging,InstituteonAlcoholAbuseand
Alcoholism, Bethesda, USA
AngelicaM. Morales
David Geffen SchoolofMedicine, University ofCalifornia at LosAngeles,
Los Angeles,CA, USA
Michael A.Nader
Department ofPhysiology andPharmacology, Wake Forest School ofMedicine,
Winston-Salem, NC, USA
Mohammad-Ali Oghabian
Research Center forMolecular and Cellular Imaging,and Advanced Diagnostic
and InterventionalRadiologyResearchCenter,TehranUniversity ofMedical
Sciences, Tehran, Iran
Vani Pariyadath
NeuroimagingResearchBranch,Intramural Research Program, National
Institute on Drug Abuse, National InstitutesofHealth,Baltimore, MD, USA
Muhammad A.Parvaz
DepartmentsofPsychiatry&Neuroscience,IcahnSchoolofMedicineatMount
Sinai,NY, USA
Martin P. Paulus
VA SanDiego Healthcare System and Department ofPsychiatry, University of
CaliforniaSan Diego, LaJolla, CA,and Laureate Institute for Brain Research,
Tulsa, OK, USA
TomasPaus
Rotman Research Institute,University ofToronto,Toronto,ON, Canada
GodfreyPearlson
Department ofPsychiatry, YaleUniversity SchoolofMedicine, New Haven, CT,
USA
BorisB. Quednow
Experimental and Clinical Pharmacopsychology, Department ofPsychiatry,
Psychotherapy and Psychosomatics, Psychiatric Hospital, University ofZurich,
andNeuroscienceCentreZurich,UniversityofZurichandSwissFederalInstitute
ofTechnology(ETH), Zurich,Switzerland
x Contributors
TaraRezapour
ResearchCenter for MolecularandCellular Imaging,TehranUniversity of
MedicalSciences, and Translational Neuroscience Program, Institutefor
Cognitive Science Studies, Tehran, Iran
(cid:1)
ReneeSchluter
DepartmentofPsychiatry,UniversityofAmsterdam,Amsterdam,TheNetherlands
Lianne Schmaal
Department ofPsychiatry, VUUniversity Medical Center,Amsterdam,
The Netherlands
Gunter Schumann
Institute ofPsychiatry, King’sCollege London, London,UK
Yavin Shaham
Behavioral NeuroscienceResearchBranch,Intramural Research Program,
NIDA,NIH, Baltimore, MD, USA
Alireza Shahbabaie
NeurocognitiveLaboratory,Iranian NationalCenter for AddictionStudies
(INCAS); Translational Neuroscience Program, Institute for Cognitive Science
Studies (ICSS), and Neuroimaging and Analysis Group, Research Center for
MolecularandCellularImaging(RCMCI),TehranUniversityofMedicalSciences,
Tehran, Iran
Rajita Sinha
Department ofPsychiatry, YaleUniversity School of Medicine,New Haven,CT,
USA
ZsuzsikaSjoerds
MaxPlanckInstituteforHumanCognitiveandBrainSciences,Leipzig,Germany
Emily Skarda
NationalInstituteonAlcoholAbuseandAlcoholism,NationalInstitutesofHealth,
Bethesda, MD, USA
MehmetSofuoglu
DepartmentofPsychiatry,SchoolofMedicine,YaleUniversity,NewHaven,and
VA ConnecticutHealthcareSystem, WestHaven,CT, USA
NadiaSolowij
SchoolofPsychology, University ofWollongong, Wollongong,NSW,Australia
DanJ. Stein
DepartmentofPsychiatryandMRCUnitonAnxiety&StressDisorders,University
of Cape Town, Cape Town, SouthAfrica
ElliotA. Stein
Intramural ResearchProgram—Neuroimaging Research Branch,National
Institute on Drug Abuse,and Neuroimaging ResearchBranch,Intramural
ResearchProgram, NationalInstituteon Drug Abuse, National Institutesof
Health, Baltimore, MD, USA
Contributors xi
JenniferL. Stewart
DepartmentofPsychology,QueensCollege,CityUniversityofNewYork,NY,USA
Julie C.Stout
SchoolofPsychologicalSciencesandMonashInstituteofCognitiveandClinical
Neuroscience, Monash University, Clayton,VIC, Australia
Susan Tapert
LaureateInstitute for Brain Research,Tulsa, OK, USA
Rachel E.Thayer
Department ofPsychology &Neuroscience, University ofColorado Boulder,
Boulder,CO, USA
Paul M.Thompson
Department ofNeurology, Imaging Genetics Center, Keck School of Medicine,
University ofSouthern California,MarinadelRey,CA, USA
Massimo Ubaldi
SchoolofPharmacy,PharmacologyUnit,UniversityofCamerino,Camerino,Italy
Anne Uhlmann
DepartmentofPsychiatryandMRCUnitonAnxiety&StressDisorders,University
ofCape Town, Cape Town, South Africa
Ruth vanHolst
Department ofPsychiatry, University ofAmsterdam, Amsterdam, The
Netherlands
Jasmin Vassileva
Department ofPsychiatry, Institute for Drug and Alcohol Studies, Virginia
CommonwealthUniversity, Richmond,VA, USA
Dick Veltman
Department ofPsychiatry, VUUniversity MedicalCenter,Amsterdam, The
Netherlands
Marco Venniro
Behavioral Neuroscience Research Branch,Intramural Research Program,
NIDA,NIH, Baltimore, MD, USA, and Department of Public Health and
Community Medicine,NeuropsychopharmacologyLaboratory, Section of
Pharmacology, University ofVerona, Verona, Italy
Nora D.Volkow
NationalInstituteon Alcohol AbuseandAlcoholism, and National Instituteon
Drug Abuse,NationalInstitutes ofHealth,Bethesda,MD,USA
HenrikWalter
Department ofPsychiatry and Psychotherapy, Charit(cid:1)e Universitatsmedizin,
Berlin, Germany
Gene-Jack Wang
NationalInstituteonAlcoholAbuseandAlcoholism,NationalInstitutesofHealth,
Bethesda, MD, USA
xii Contributors
Corinde E.Wiers
Department ofPsychiatryandPsychotherapy,Charit(cid:1)e—Universita¨tsmedizin;
BerlinSchoolofMindandBrain,Humboldt-Universita¨tzu,Berlin,Germany,and
NationalInstituteonAlcoholAbuseandAlcoholism,NationalInstitutesofHealth,
Bethesda, MD, USA
Reinout W.Wiers
Addiction Development and Psychopathology (ADAPT) Lab,Department of
Psychology, University ofAmsterdam, Amsterdam,The Netherlands
Margaret J. Wright
QIMR BerghoferMedicalResearchInstitute,Brisbane, QLD, Australia
Fatemeh Yavari
NeurocognitiveLaboratory,Iranian NationalCenter for AddictionStudies
(INCAS), Tehran University ofMedicalSciences, Tehran, Iran
MuratYucel
SchoolofPsychologicalSciences, Monash Institute ofCognitive and Clinical
Neurosciencesand Monash Biomedical Imaging,Monash University,
Melbourne, Australia
Deborah Yurgelun-Todd
DepartmentofPsychiatry,UniversityofUtahSchoolofMedicine,SaltLakeCity,
UT, USA
AnnaZilverstand
DepartmentsofPsychiatry&Neuroscience,IcahnSchoolofMedicineatMount
Sinai,NY, USA